FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea FDA considers adding a dozen peptides to its bulk drug compounding list RAPS The internet says BPC 157 is banned the FDA says something more nuanced. At Moonshot Medical in Park Ridge, IL, we provide honest, current guidance on peptide therapy through licensed compounding pharmacies. FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA to weigh easing limits on unproven peptides promoted by RFK Jr.